RCC, CLEAR CELL ADENOCARCINOMA

Clinical trials for RCC, CLEAR CELL ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RCC, CLEAR CELL ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for RCC, CLEAR CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New immune therapy trial opens for Tough-to-Treat cancers

Disease control Recruiting now

This early-stage trial is testing a new immune therapy drug called ADU-1805, both alone and combined with an existing cancer drug (pembrolizumab). It aims to find safe doses and see if the treatment helps control advanced solid tumors that haven't responded to standard treatments…

Matched conditions: RCC, CLEAR CELL ADENOCARCINOMA

Phase: PHASE1 • Sponsor: Sairopa B.V. • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

RCC, CLEAR CELL ADENOCARCINOMA

Get alerted when new RCC, CLEAR CELL ADENOCARCINOMA trials appear

New immune therapy trial opens for Tough-to-Treat cancers